Literature DB >> 30406745

The Relevance of Irreversible Loss of Brain Function as a Reliable Sign of Death.

Stephan A Brandt1, Heinz Angstwurm2.   

Abstract

BACKGROUND: There is an ongoing need for clear explanation of the diagnostic entity called "irreversible loss of brain function" (ILBF), as the absolute reliability of this diagnosis and its significance continue to be widely misunderstood. The determination of death as an objective medical-scientific matter is often not clearly distinguished from various other aspects of death, such as its metaphysical and cultural aspects and the ways in which the living deal with the dead.
METHODS: This review is based on articles retrieved by a selective literature search in the PubMed database and on guidelines and standardized diagnostic protocols from Germany and abroad.
RESULTS: ILBF can be caused by brain ischemia or anoxia or by any other type of brain disease or injury leading to an elevation of the intracranial pressure above the blood pressure and thereby to an arrest of the cerebral circulation. All situations in which brain function is merely reduced but not abolished, or only temporarily but not permanently abolished, can be clearly differentiated from ILBF through the use of standard diagnostic procedures as recommended in the relevant guidelines. Biological features that are common to all human beings underlie the medical criteria for the determination of death. The most important elements of the determination of death are irreversibility of the loss of brain function, loss of integration of bodily functions into a single living being, and loss of ability for any self-reflection or any independent interaction with the environment.
CONCLUSION: ILBF is a reliable sign that a human being is dead. There has never been even one known case of incorrect determination of ILBF after proper application of the standardized diagnostic procedures that are set down in the guideline according to §16 of the German Transplantation Law.

Entities:  

Mesh:

Year:  2018        PMID: 30406745      PMCID: PMC6241146          DOI: 10.3238/arztebl.2018.0675

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  28 in total

1.  Brain death: time for an international consensus.

Authors:  M Smith
Journal:  Br J Anaesth       Date:  2012-01       Impact factor: 9.166

2.  The clinical criteria of brain death throughout the world: why has it come to this?

Authors:  Eelco F M Wijdicks
Journal:  Can J Anaesth       Date:  2006-06       Impact factor: 5.063

3.  Practice variability in brain death determination: a call to action.

Authors:  Claire N Shappell; Jeffrey I Frank; Khalil Husari; Matthew Sanchez; Fernando Goldenberg; Agnieszka Ardelt
Journal:  Neurology       Date:  2013-11-06       Impact factor: 9.910

4.  Variability in brain death determination in europe: looking for a solution.

Authors:  Giuseppe Citerio; Ilaria Alice Crippa; Alfio Bronco; Alessia Vargiolu; Martin Smith
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

5.  Brain death declaration: Practices and perceptions worldwide.

Authors:  Sarah Wahlster; Eelco F M Wijdicks; Pratik V Patel; David M Greer; J Claude Hemphill; Marco Carone; Farrah J Mateen
Journal:  Neurology       Date:  2015-04-08       Impact factor: 9.910

6.  Development of an artificial placenta: survival of isolated goat fetuses for three weeks with umbilical arteriovenous extracorporeal membrane oxygenation.

Authors:  N Unno; Y Kuwabara; T Okai; K Kido; H Nakayama; A Kikuchi; Y Narumiya; S Kozuma; Y Taketani; M Tamura
Journal:  Artif Organs       Date:  1993-12       Impact factor: 3.094

7.  Whole-brain death reconsidered--physiological facts and philosophy.

Authors:  C Pallis
Journal:  J Med Ethics       Date:  1983-03       Impact factor: 2.903

8.  ABC of brain stem death. Diagnosis of brain stem death--I.

Authors:  C Pallis
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-27

9.  Brain death worldwide: accepted fact but no global consensus in diagnostic criteria.

Authors:  Eelco F M Wijdicks
Journal:  Neurology       Date:  2002-01-08       Impact factor: 9.910

10.  The Declaration of Sydney on human death.

Authors:  C Machado; J Korein; Y Ferrer; L Portela; M de la C García; M Chinchilla; Y Machado; Y Machado; J M Manero
Journal:  J Med Ethics       Date:  2007-12       Impact factor: 2.903

View more
  9 in total

Review 1.  [Diagnosis of irreversible loss of brain function ("brain death")-what is new?]

Authors:  Uwe Walter; Stephan A Brandt
Journal:  Nervenarzt       Date:  2019-10       Impact factor: 1.214

2.  Spiritual Issues Should Be Considered.

Authors:  Alois Bahemann
Journal:  Dtsch Arztebl Int       Date:  2019-02-08       Impact factor: 5.594

3.  Metaphysical and Cultural Aspects.

Authors:  Hans-Joachim Ritz
Journal:  Dtsch Arztebl Int       Date:  2019-02-08       Impact factor: 5.594

4.  Is Irreversible Loss of Brain Function a Reliable Sign of Death?

Authors:  Markus Parzeller; Marcel A Verhoff; Barbara Zedler
Journal:  Dtsch Arztebl Int       Date:  2019-02-08       Impact factor: 5.594

5.  In Reply.

Authors:  Stephan A Brandt; Heinz Angstwurm
Journal:  Dtsch Arztebl Int       Date:  2019-02-08       Impact factor: 5.594

6.  Pertinent Points Need to Be More Convincingly Stated.

Authors:  Raimund Firsching
Journal:  Dtsch Arztebl Int       Date:  2019-02-08       Impact factor: 5.594

Review 7.  [Brain death criterion and organ donation: current neuroscientific perspective].

Authors:  Uwe Walter
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-11-12       Impact factor: 1.513

8.  Brain beats heart: a cross-cultural reflection.

Authors:  Thomas Brandt; Doreen Huppert
Journal:  Brain       Date:  2021-07-28       Impact factor: 13.501

9.  Revise the Uniform Determination of Death Act to Align the Law With Practice Through Neurorespiratory Criteria.

Authors:  Adam Omelianchuk; James Bernat; Arthur Caplan; David Greer; Christos Lazaridis; Ariane Lewis; Thaddeus Pope; Lainie Friedman Ross; David Magnus
Journal:  Neurology       Date:  2022-01-25       Impact factor: 11.800

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.